1 results match your criteria: "The No. 302 Hospital of The PIA[Affiliation]"
[Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
February 2009
Center of Clinical Laboratory, The No. 302 Hospital of The PIA, Beijing 100039, China.
Objective: To evaluate the detection method of ELISA and Enhanced Chemiluminescence Immunoassay (ECLIA) in use to determine serum hyaluronate acid (HA), laminin (LN), type IV collagen (IV-C) and type III procollagen (PC III).
Methods: 253 patients with chronic hepatitis B were determined the four liver fibrosis serum markers with both the ECLIA and ELISA, and then compared with pathology results separately.
Results: Both the detection results of ELISA and ECLIA can reflect that the patient's liver fibrosis from hepatitis to liver cirrhosis aggravated gradually.